Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01047878 · ClinicalTrials.gov registry record
Genomic Analysis of Pediatric Bone Tumors
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 163
- Enrollment target
NCT01047878: Completed study, sponsored by Stanford University.
NCT01047878 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 163 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01047878 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 163 participants
- Enrollment target
Study Summary
To determine whether gene expression analysis of primary tumor samples before and after chemotherapy are predictive of long-term survival in pediatric patients with bone sarcomas (Ewings sarcoma (ES) and Osteosarcoma(OS)).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2007-08 |
| Est. Completion | 2019-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01047878
The ClinicalTrials.gov registry entry for NCT01047878 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 163 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01047878 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01047878 about?
NCT01047878 is a clinical study titled "Genomic Analysis of Pediatric Bone Tumors". To determine whether gene expression analysis of primary tumor samples before and after chemotherapy are predictive of long-term survival in pediatric patients with bone sarcomas (Ewings sarcoma (ES) and Osteosarcoma(OS)).
What is the current status of trial NCT01047878?
This trial is currently completed. The enrollment target is 163 participants. The study started on 2007-08. Estimated completion is 2019-12.
Who is sponsoring clinical trial NCT01047878?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.